Stay tuned and follow the latest
developments and news in Molecular Oncology.
Genekor’s scientific team, from the very first days of its establishment, has focused on the use and development of new technologies and the quality of services provided. In this way […]
Read More
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer • First results from the independent SWOG […]
Read More
PrIMe – “Precision Individualized Medicine”The new Genekor Medical S.A. PrIMe gene test with 500+ genes and the biomarkers MSI, TBM and PD-L1 in patients with solid tumors has been officially […]
Read More
The use of TMB mutation load detection as a biomarker for the selection of pembrolizumab (Keytruda™) as a treatment for adult and pediatric patients with unresectable or metastatic solid tumors […]
Read More
Every human body is different. So a pharmaceutical substance cannot have the same effect on all people. A treatment may be highly beneficial for one person and for another it […]
Read More
COMMUNITIES MAKE THE DIFFERENCE Each year, on 1 December, the world commemorates World AIDS Day. People around the world unite to show support for people living with HIV and to […]
Read More
Cancer has become an extremely common disease nowadays, which should not be surprising when almost every family seems to have people with a history of cancer. Based on the findings […]
Read More
The past few decades the identification of cancer biomarkers has become a major project in cancer research. A tumor marker is anything present in or produced by cancer cells or […]
Read More
Precision medicine is an innovative approach to patient care and it has become a reality in today’s scientific society. A better genetic understanding of each and every disease may be […]
Read More